3I Group PLC

Price Chart

Risk-Adjusted Performance

Also Listed On

3I Group PLC (III) Price Performance

3I Group PLC (III) trades on London Stock Exchange in GBX. The company is classified in the Financial Services sector under the Asset Management industry. The stock currently trades at GBX2773.00, down 2.29% from the previous close.

Over the past year, III has traded between a low of GBX2299.00 and a high of GBX4408.86. The stock has lost 32.4% over this period. It is currently 37.1% below its 52-week high.

3I Group PLC has a market capitalization of $29.60B, with a price-to-earnings ratio of 4.48 and a dividend yield of 2.84%.

About 3I Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co